Screener
Recursion Pharmaceuticals, Inc. RXRX Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The source filing: Recursion Pharmaceuticals, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:32 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001601830-26-000098
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Total liabilities | 297,665 | 343,265 |
| Commitments and contingencies (Note 7) | ||
| Stockholders’ equity | ||
| Common stock, $0.00001 par value; 2,000,000,000 shares (Class A 1,989,032,117 and Class B 10,967,883) authorized as of June 30, 2026 and December 31, 2025; 534,120,235 shares (Class A 533,191,318, Class B — and Exchangeable 928,917) and 528,182,693 shares (Class A 521,831,046, Class B 5,547,334 and Exchangeable 804,313) issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 5 | 5 |
| Additional paid-in capital | 3,211,515 | 3,170,145 |
| Accumulated deficit | (2,324,511) | (2,076,002) |
| Accumulated other comprehensive income | 27,994 | 36,717 |
| Total stockholders’ equity | 915,003 | 1,130,865 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Recursion Pharmaceuticals, Inc.'s common stock?
- Recursion Pharmaceuticals, Inc. (RXRX) reported common stock of 2B in Q2 2026.
- How has Recursion Pharmaceuticals, Inc.'s common stock changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s common stock decreased by 0.0% year-over-year, from 2B to 2B.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Recursion Pharmaceuticals, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude